PNOĒ Puts an Eight-Minute VO₂ Max Test on the Gym Floor
PNOĒ's redesigned breath-analysis mask arrives October 1 with an eight-minute, operator-free protocol — pushing clinical metabolic testing out of the lab and onto the gym floor.
PNOĒ, a Malden, Massachusetts-based metabolic testing startup, is launching a redesigned self-serve breath-analysis mask on October 1 that measures VO₂ max and other metabolic markers in an eight-minute test without a trained operator.
PNOĒ, a metabolic testing company headquartered in Malden, Massachusetts, is putting a version of its breath-analysis mask into gyms on October 1 that does not need a technician standing next to it. The redesigned hardware runs an eight-minute protocol and returns VO₂ max and other metabolic markers to the person wearing it, according to TechCrunch. The older unit, by the company's own reckoning, looked uncomfortably like the mask worn by the Batman villain Bane. The new one does not.
That sounds like a cosmetic note. It is not. The single largest barrier to metabolic testing reaching consumers has never been the science — it has been the choreography: a lab, an appointment, a trained operator, a calibration routine, and a mask that most people would not be caught dead wearing in front of strangers. Strip out the operator and shrink the protocol to eight minutes and the economics of the test change completely.
What a breath test actually measures, and why gyms want it
VO₂ max is the maximum volume of oxygen a body can take in and use during hard effort. It is the closest thing exercise physiology has to a single-number readout of aerobic capacity, and it is one of the better-studied correlates of long-term cardiovascular health. A metabolic cart — the machine PNOĒ is miniaturising — derives it by sampling the air you breathe out and comparing the oxygen and carbon dioxide fractions against what went in. From the same gas exchange you can infer which fuel the body is burning at a given intensity, roughly where aerobic effort tips into anaerobic, and how much energy is being spent at rest.
Wearables approximate the same number from heart rate, pace and demographic inputs. They are estimates, not measurements, and they are estimates built on population models rather than the individual in front of them. The pitch for a breath test is that it measures the gas directly instead of modelling it from proxies. That distinction is the entire value proposition, and it is also the thing PNOĒ will have to keep defending as smartwatch algorithms improve.
For a gym operator, the appeal is straightforward. A self-serve station is a piece of equipment with a floor footprint and a utilisation rate, not a service line requiring payroll. It gives a trainer something concrete to build a program around and gives a member a reason to come back and retest. Fitness chains have spent years hunting for premium add-ons that justify a higher membership tier — body composition scanners, recovery rooms, saunas. A device that hands a member a lab-style metabolic profile in the time it takes to warm up fits that template neatly.
The operator is the cost, not the hardware
Traditional VO₂ max testing happens in a sports-medicine clinic or a university physiology lab. A technician fits the mask, checks the seal, calibrates the gas analysers, runs the treadmill or bike ramp protocol, and interprets the output. Labour dominates the cost, and scheduling dominates the friction. Removing the operator is therefore not a modest efficiency gain — it is the difference between a service that is booked weeks out and a machine that anyone can walk up to.
The engineering problem hiding underneath is quality control. In a lab, the operator is also the error check: they notice a leaking mask seal, an uncooperative sensor, or a subject who stopped short of true maximal effort. A self-serve unit has to catch those failure modes in software and either correct for them or refuse to report a number. How aggressively PNOĒ's device flags bad tests will say more about its credibility than any marketing claim about accuracy.
The eight-minute window is the other signal worth reading. Classical maximal-effort protocols push a subject to exhaustion and can run considerably longer than that. A short protocol implies either a submaximal test with an extrapolation step, or a steeply ramped one designed to reach the ceiling fast. Either approach is defensible; each carries its own error characteristics. Buyers — gym operators writing cheques, and members trusting the output — should ask which one they are getting.
A consumer health category being built one measurement at a time
Classical maximal-effort protocols push a subject to exhaustion and can run considerably longer than that.
PNOĒ's launch lands in the middle of a broader push to move clinical-grade measurement out of clinical settings. Continuous glucose monitors moved from diabetes management to general-population biohacking. Home blood panels, DEXA scans in shopping centres, and sleep-stage tracking on the wrist all followed the same arc: a measurement that used to require a referral becomes a retail purchase. Metabolic gas exchange is one of the last major lab tests that has resisted that migration, largely because the hardware was bulky and the procedure needed supervision.
The commercial question is whether members will pay repeatedly. A one-off VO₂ max reading is a novelty. The business only works if the test becomes a recurring metric — a quarterly benchmark that shows a training block worked, or that it did not. That means retest pricing, data continuity across sessions, and an interpretation layer that turns gas-exchange numbers into something a non-specialist can act on. Hardware in the corner of a gym is the easy part.
Where the market backdrop sits
PNOĒ is privately held, so there is no stock to read the launch against. The public market context is broadly supportive of consumer hardware launches heading into the fourth quarter: at the last close on Friday, 25 September 2026, the S&P 500 tracker (NYSEARCA: SPY) finished at $771.35, up 0.54% on the day, with the Nasdaq 100 tracker (NASDAQ: QQQ) at $744.50, up 0.46%, and the Dow tracker (NYSEARCA: DIA) at $517.49, up 0.94%. None of those move on a gym device, but they frame a market that has not been closing the window on health-tech fundraising.
What to watch after October 1: how many facilities actually deploy the unit rather than pilot it; whether results from the self-serve protocol hold up against supervised lab tests when researchers get hold of them; and whether smartwatch makers respond by tightening their own VO₂ max estimates. The fastest way to commoditise a measurement is for a device people already own to get good enough at approximating it. PNOĒ's defence is that a direct measurement and a model are not the same thing — a claim that now gets tested in public, eight minutes at a time.
Key facts
- Launch date: October 1, 2026, for the self-serve mask
- Test duration: Eight minutes, no trained operator required
- Company base: Malden, Massachusetts (privately held)
- Market backdrop: SPY closed at $771.35, +0.54%, as of Fri, 25 Sep 2026 20:00 GMT
Frequently asked questions
What is PNOĒ launching on October 1?
PNOĒ, a Malden, Massachusetts-based startup, is launching a redesigned, sleeker version of its breath-analyzing face mask built for self-serve use. The device measures VO₂ max and other metabolic markers in an eight-minute test and does not require a trained operator to run it, making it suitable for placement on a gym floor.
What does VO₂ max measure?
VO₂ max is the maximum volume of oxygen the body can take in and use during intense exercise. It is a standard measure of aerobic capacity in exercise physiology and is widely studied as a correlate of cardiovascular fitness and long-term health. It is traditionally measured in a lab using a metabolic cart that analyses exhaled breath.
How is breath testing different from a smartwatch estimate?
A smartwatch infers VO₂ max from heart rate, pace and demographic inputs using population-level models — it is an estimate. A breath-analysis device measures the oxygen and carbon dioxide content of air you actually exhale, deriving the figure from direct gas exchange rather than from proxies. That measurement-versus-model distinction is the core of PNOĒ's pitch.
Why does removing the trained operator matter?
In conventional VO₂ max testing, labour is the dominant cost and scheduling is the dominant friction: a technician fits the mask, calibrates the analysers and supervises the protocol. A self-serve unit turns the test from a booked clinical service into a piece of gym equipment with a utilisation rate, changing both the price structure and how often people can take it.
Is PNOĒ a publicly traded company?
No. PNOĒ is a privately held startup based in Malden, Massachusetts, so there is no exchange-listed stock tied to this product launch. Investors cannot take a direct position in the company through public markets, and any read-through is limited to the broader consumer health-technology and fitness-equipment sectors.
What should buyers ask about an eight-minute protocol?
Classical maximal-effort VO₂ max tests push a subject to exhaustion and typically run longer than eight minutes. A shorter protocol implies either a submaximal test with an extrapolation step or a steeply ramped one. Each approach has different error characteristics, so gym operators and members should ask which method the device uses and how it flags invalid tests.
